Identifying the etiological agent of sepsis or community-acquired pneumonia (CAP) greatly improves the clinician's ability to manage the patient. Even with all of the newly developed technologies of molecular diagnostics, there have been essentially no recent innovations in diagnostic testing for these significant and often life threatening diseases. Blood culture, microbial sugar utilization-based identification, and empirical chemotherapy have dominated diagnostics and patient management decisions for several years. Empirical treatment - often inappropriate - is partially responsible for the epidemic spread of multidrug resistant ? pathogens. Bacterial, fungal, and viral agents can all be concurrently detected and identified with nucleic acid amplification and hybridization methods. Innovative approaches to nucleic acid isolation from clinical samples, coupled with multiplex PCR amplification, and detection on electronic microarrays has the potential to significantly advance the ability of the clinician to correctly identify the underlying pathogen and manage the disease. This proposal describes a program to merge innovative, yet proven technology for sample preparation, high multiplex amplification, and detection and differentiation with biomarkers identifying at least 17 agents of CAP and sepsis with an automated system for the clinical microbiology laboratory. The investigators have all made significant contributions in commercializing new molecular diagnostic systems for detection and identification of pathogens in the areas of: respiratory viruses, blood banking, sexually transmitted disease, bioterrorism, CAP, and sepsis.
The specific aims are: (1) Optimize a multiplex PCR system including bacterial and viral CAP and sepsis agent targets; (2) Select a suitable sample preparation chemistry; (3) Optimize the assay on electronic microarrays; (4) Develop self-contained modules for the three assay steps; (5) Integrate the modules into a prototype disposable, on a prototype instrument; (6) Develop processes and specifications for critical raw materials; and (7) Test the prototype integrated assay in a clinical study. At the completion of the research program, a number of useful tools will be available to improve molecular diagnostic methods for CAP and sepsis (and potentially other diseases), and a fully ? integrated automated assay that will be in the final stages of commercialization. ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01AI066584-02
Application #
7091568
Study Section
Special Emphasis Panel (ZAI1-SR-M (M1))
Program Officer
Korpela, Jukka K
Project Start
2005-07-01
Project End
2010-06-30
Budget Start
2006-08-01
Budget End
2007-07-31
Support Year
2
Fiscal Year
2006
Total Cost
$467,830
Indirect Cost
Name
Nanogen, Inc.
Department
Type
DUNS #
840610273
City
San Diego
State
CA
Country
United States
Zip Code
92121
Rebuffo-Scheer, Cecilia; Bose, Michael; He, Jie et al. (2011) Whole genome sequencing and evolutionary analysis of human respiratory syncytial virus A and B from Milwaukee, WI 1998-2010. PLoS One 6:e25468
Nelson, Martha I; Tan, Yi; Ghedin, Elodie et al. (2011) Phylogeography of the spring and fall waves of the H1N1/09 pandemic influenza virus in the United States. J Virol 85:828-34
Kumar, Swati; Chusid, Michael J; Willoughby, Rodney E et al. (2010) Epidemiologic Observations from Passive and Targeted Surveillance during the First Wave of the 2009 H1N1 Influenza Pandemic in Milwaukee, WI. Viruses 2:782-795
Kumar, Swati; Chusid, Michael J; Willoughby, Rodney E et al. (2009) Introduction of a Novel Swine-Origin Influenza A (H1N1) Virus into Milwaukee, Wisconsin in 2009. Viruses 1:72-83
He, Jie; Kraft, Andrea J; Fan, Jiang et al. (2009) Simultaneous Detection of CDC Category ""A"" DNA and RNA Bioterrorism Agents by Use of Multiplex PCR & RT-PCR Enzyme Hybridization Assays. Viruses 1:441-459
He, Jie; Bose, Michael E; Beck, Eric T et al. (2009) Rapid multiplex reverse transcription-PCR typing of influenza A and B virus, and subtyping of influenza A virus into H1, 2, 3, 5, 7, 9, N1 (human), N1 (animal), N2, and N7, including typing of novel swine origin influenza A (H1N1) virus, during the 2009 o J Clin Microbiol 47:2772-8
Bose, Michael E; Beck, Eric T; Ledeboer, Nate et al. (2009) Rapid semiautomated subtyping of influenza virus species during the 2009 swine origin influenza A H1N1 virus epidemic in Milwaukee, Wisconsin. J Clin Microbiol 47:2779-86
Huang, Ying; Tang, Huong; Duffy, Stuart et al. (2009) Multiplex assay for simultaneously typing and subtyping influenza viruses by use of an electronic microarray. J Clin Microbiol 47:390-6
Kumar, Swati; Wang, Lihua; Fan, Jiang et al. (2008) Detection of 11 common viral and bacterial pathogens causing community-acquired pneumonia or sepsis in asymptomatic patients by using a multiplex reverse transcription-PCR assay with manual (enzyme hybridization) or automated (electronic microarray) detec J Clin Microbiol 46:3063-72